DEUTSCH
SITEMAP
for
Beginners
for
Vaccperts
for
Investors
for
Careers
Sitemap
main
for
Beginners
News
Archive 2010
Archive 2009
Archive 2008
Archive 2007
Archive 2006
Archive 2005
Latest Reports
RSS News
Company
Corporate Team
Management
Thomas Lingelbach
Staph Leavenworth Bakali
Reinhard Kandera
Supervisory Board
Thomas Szucs
Ernst Guenter Afting
Michel Gréco
James Sulat
Hans Wigzell
Alexander von Gabain
Scientific Advisory Board
Company Presentation
Locations
Intercell Headquarters
Intercell USA, Inc.
Intercell Biomedical Ltd.
CSR
CSR mission statement
Economy
Managing our environmental footprint
Social accountability
Annual Report
Healthcare in Nepal
CSR Contact
Contact
for
Vaccperts
Product Pipeline
Products
Japanese Encephalitis vaccine
Pseudomonas vaccine
Clostridium difficile vaccine
Hepatitis C virus vaccine
Pandemic Influenza vaccine patch
Tuberculosis vaccine
Partnerships
Technologies
Antigen Identification Program® (AIP®)
Adjuvant IC31®
Vaccine Patch
Monoclonal antibodies (mAbs)
for
Investors
Stock Information
ADR Information
Shareholder Structure
Analysts
Annual General Meeting
Annual General Meeting 2010
Annual General Meeting 2009
Financial Calendar
Conferences
Open House 2011
Open House 2010
Shareholder Day 2009
Shareholder Day 2008
RSS Events
Archive
Downloads
Annual Reports
Quarterly Reports
Presentations
Annual Document
Treasury Stock
Directors' Dealings
Movies
Corporate Governance
Management
Corporate Social Responsibility
Directors' Dealings
Treasury Stock
Corporate Actions & Announcements
EUR 33.0 million Convertible Note 2011
Convertible Bonds - Publications
Acquisition of Iomai Corporation
Novartis Capital Increase
Intercell - Second Public Offering
Intercell - Initial Public Offering
Investors Q&As
IR Contact
for
Careers
Job Offers
Career Benefits
Investors in People Award
Sustainability & CSR
HR Contact
